Trastuzumab Recruiting Phase 1 Trials for Tumors, Solid / Cancer of Head and Neck / Breast Cancer Treatment

RecruitingTreatment1 IdentifierTitleDrugs
NCT02627274A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)
NCT01969643A Safety Study of SGN-LIV1A in Breast Cancer Patients
NCT03716180DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
NCT03135171Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab